Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Canadian Journal of Microbiology|March 31, 2004
Genetic diversity of rhizobia nodulating Trifolium ambiguum in North AmericaP Seguin, P H Graham, C C Sheaffer, et al.
Canadian Journal of Microbiology|February 17, 2005
Characteristics of rhizobia nodulating beans in the central region of MinnesotaG R Bernal, B Tlusty, C Estevez de Jensen, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 22, 2018
Endoscopic dilatation improves long-term dysphagia following head and neck cancer therapies: a randomized control trialP I Wu, M M Szczesniak, J Maclean, et al.
Systematic and Applied Microbiology|December 20, 1999
Phylogeny and diversity of Bradyrhizobium strains isolated from the root nodules of peanut (Arachis hypogaea) in Sichuan, ChinaX Zhang, G Nick, S Kaijalainen, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 16, 2006
A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal-cord compression treated by radiotherapy: TROG 01.05 Superdex studyP H Graham, A Capp, G Delaney, et al.
Cell Death & Disease|October 26, 2013
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistanceL Chang, P H Graham, J Hao, et al.
Cell Death & Disease|October 3, 2014
PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathwaysL Chang, P H Graham, J Hao, et al.
Australasian Radiology|August 4, 2006
Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapyP H Graham, C Clark, F Abell, et al.
Journal of Medical Imaging and Radiation Oncology|June 17, 2009
Radioresistant malignant myoepithelioma of the breast with high level of ataxia telangiectasia mutated proteinZ M Fang, R V Tse, V M Marjoniemi, et al.
British Journal of Cancer|June 30, 2011
Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53E K A Millar, P H Graham, C M McNeil, et al.
Pageof 4